低覆盖度基因组测序在产前样本中诊断效用的前瞻性评估:与染色体微阵列分析比较
本研究前瞻性纳入200例羊水样本,比较低覆盖度基因组测序(LC-GS,3X覆盖度)与染色体微阵列分析(CMA)及核型分析在产前诊断中的效能。LC-GS检出77例阳性样本(检出率38.5%),包括17例非整倍体、36例拷贝数变异(CNV)、20例纯合区域(ROH)和8例染色体嵌合;与CMA高度一致,诊断产出为21%(42/200),且成本更低,在亚显微CNV分辨率上优于CMA。
要点
- LC-GS在3X覆盖度下检出77/200例阳性(38.5%),涵盖非整倍体、CNV、ROH和染色体嵌合。
- LC-GS与CMA在非整倍体、CNV、ROH和染色体嵌合检测上高度一致,诊断产出为21%(42/200)。
- LC-GS在亚显微CNV分辨率上优于CMA,并具有降低成本的优势。
核心结论
- LC-GS是产前诊断中CMA的稳健替代方案,可有效识别非整倍体、CNV、染色体嵌合和ROH,在广谱基因组异常检测中提供与CMA相当的敏感性和特异性。
研究设计与样本
- 前瞻性研究纳入200例羊水样本,所有样本均进行LC-GS(3X覆盖度)及传统检测(CMA和核型分析),比较两种方法的敏感性、特异性和整体临床效用。
主要发现
- LC-GS在3X深度下检出77例阳性样本,检出率为38.5%(77/200)。
- 阳性样本包括17例非整倍体、36例CNV、20例ROH和8例染色体嵌合。
- LC-GS与CMA在非整倍体、CNV、ROH和染色体嵌合检测上高度一致,诊断产出为21%(42/200),并具有降低成本的优势。
- LC-GS在识别亚显微CNV的分辨率上优于CMA。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The present study aimed to evaluate the efficacy of LC-GS in detecting clinically relevant chromosomal abnormalities in comparison with conventional CMA within a prenatal context. METHODS: We conducted a prospective study involving 200 amniotic fluid samples. All specimens were analyzed via LC-GS and traditional tests, including CMA and karyotyping. LC-GS was performed with 3X coverage to gauge its proficiency in identifying copy number variations (CNVs), aneuploidies, regions of homozygosity (ROH), and chromosome mosaicism. Data from both methods were compared to evaluate their sensitivity, specificity, and overall clinical utility. RESULTS: LC-GS at a depth of 3X identified a total of 77 positive samples, yielding a detection rate of 38.5% (77/200). This included 17 cases of aneuploidy, 36 instances of CNVs, 20 cases linked to ROH, and 8 cases of chromosomal mosaicism. LC-GS demonstrated high concordance with CMA in aneuploidy, CNVs, ROH, and chromosomal mosaicism, achieving a diagnostic yield of 21% (42/200), with additional benefits of reduced cost. Moreover, LC-GS outperformed CMA in terms of resolution for identifying submicroscopic CNVs. CONCLUSION: LC-GS presents a robust alternative to CMA for prenatal diagnosis, effectively identifying aneuploidies, CNVs, chromosomal mosaicism, and ROH. It delivers comparable sensitivity and specificity in the detection of a wide spectrum of genomic abnormalities.
引用
- Yin Y, He Y, Chen C, et al. A Prospective Evaluation of the Diagnostic Utility for Low-Coverage Genome Sequencing in Prenatal Samples: A Comparison With Chromosomal Microarray Analysis. Prenat Diagn. 2025. PMID: 40616234. doi:10.1002/pd.6840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。